000766 通化金马
已收盘 08-23 15:00:00
资讯
新帖
简况
通化金马(000766)8月21日主力资金净卖出4437.36万元
证券之星 · 08-22 09:22
通化金马(000766)8月21日主力资金净卖出4437.36万元
通化金马(000766)2024年中报简析:净利润增15.7%,盈利能力上升
证券之星 · 08-22 06:07
通化金马(000766)2024年中报简析:净利润增15.7%,盈利能力上升
图解通化金马中报:第二季度单季净利润同比减13.96%
证券之星 · 08-20
图解通化金马中报:第二季度单季净利润同比减13.96%
通化金马最新公告:聘任张玉富先生担任公司总经理
证券之星 · 08-20
通化金马最新公告:聘任张玉富先生担任公司总经理
通化金马最新公告:2024年上半年净利润同比增长15.69%
证券之星 · 08-20
通化金马最新公告:2024年上半年净利润同比增长15.69%
通化金马(000766.SZ)发布上半年业绩,净利润1246.83万元,增长15.69%
智通财经 · 08-20
通化金马(000766.SZ)发布上半年业绩,净利润1246.83万元,增长15.69%
通化金马:公司正严格按照CDE有关法律、法规及指导原则,积极开展新药上市申请有关工作
证券之星 · 08-14
通化金马:公司正严格按照CDE有关法律、法规及指导原则,积极开展新药上市申请有关工作
通化金马(000766)8月13日主力资金净卖出1401.11万元
证券之星 · 08-14
通化金马(000766)8月13日主力资金净卖出1401.11万元
通化金马:根据《股票上市规则》等要求,公司对达到信息披露标准的事项,将会及时披露
证券之星 · 08-12
通化金马:根据《股票上市规则》等要求,公司对达到信息披露标准的事项,将会及时披露
通化金马:相关信息请查询国家药品监督管理局药品审评中心官网
证券之星 · 08-08
通化金马:相关信息请查询国家药品监督管理局药品审评中心官网
通化金马:公司按照国家有关规定,加快推进新药注册进度,并根据进展情况及时履行信息披露义务
证券之星 · 08-05
通化金马:公司按照国家有关规定,加快推进新药注册进度,并根据进展情况及时履行信息披露义务
7月31日通化金马涨5.27%,南方中证1000ETF基金重仓该股
证券之星 · 07-31
7月31日通化金马涨5.27%,南方中证1000ETF基金重仓该股
通化金马:原料药上市申请为新药上市申请关联审评的重要环节
证券之星 · 07-30
通化金马:原料药上市申请为新药上市申请关联审评的重要环节
通化金马:根据《股票上市规则》等要求,公司对达到信息披露标准的事项,将会及时披露
证券之星 · 07-29
通化金马:根据《股票上市规则》等要求,公司对达到信息披露标准的事项,将会及时披露
医药股盘初走低,一品红跌超16%,康缘药业跌逾8%,新天药业、通化金马、博瑞医药、键凯科技等跟跌。
华尔街见闻 · 07-29
医药股盘初走低,一品红跌超16%,康缘药业跌逾8%,新天药业、通化金马、博瑞医药、键凯科技等跟跌。
通化金马:我公司自主研发的琥珀八氢氨吖啶片,为国家1.1类新药
证券之星 · 07-26
通化金马:我公司自主研发的琥珀八氢氨吖啶片,为国家1.1类新药
7月26日通化金马跌6.66%,南方中证1000ETF基金重仓该股
证券之星 · 07-26
7月26日通化金马跌6.66%,南方中证1000ETF基金重仓该股
【午后一度跌停,通化金马回应:生产经营一切正常,后续会提交琥珀八氢氨吖啶片剂上市申请】金十数据7月26日讯,通化金马午后大跌,一度触及跌停。
美港电讯 · 07-26
【午后一度跌停,通化金马回应:生产经营一切正常,后续会提交琥珀八氢氨吖啶片剂上市申请】金十数据7月26日讯,通化金马午后大跌,一度触及跌停。
通化金马闪崩跌超9%,成交额超5亿元。该股昨日盘初亦闪崩跌超8%。
美港电讯 · 07-26
通化金马闪崩跌超9%,成交额超5亿元。该股昨日盘初亦闪崩跌超8%。
解构“妖股” 通化金马
每日经济新闻 · 07-25
解构“妖股” 通化金马
暂无数据
公司概况
公司名称:
通化金马药业集团股份有限公司
所属行业:
医药制造业
上市日期:
1997-04-30
主营业务:
通化金马药业集团股份有限公司主要从事医药产品的研发、生产与销售。主要产品有复方嗜酸乳杆菌片、风湿祛痛胶囊、清肝健脾口服液、芩石利咽口服液。公司经历多年发展,获得行业认可,荣获“中华民族医药百强品牌企业”,2023年获得“2022-2023年度中国医药制造业百强”等称号。子公司圣泰生物先后被评为哈尔滨市“小巨人”企业、黑龙江省民营科技“巨星”企业、黑龙江省专精特新小巨人企业、国家高新技术企业、国家火炬计划重点高新技术企业等多项荣誉。
发行价格:
7.23
{"stockData":{"symbol":"000766","market":"SZ","secType":"STK","nameCN":"通化金马","latestPrice":13.23,"timestamp":1724396634000,"preClose":12.86,"halted":0,"volume":12004640,"delay":0,"floatShares":966000000,"shares":966000000,"eps":0.0473,"marketStatus":"已收盘","marketStatusCode":5,"change":0.37,"latestTime":"08-23 15:00:00","open":12.82,"high":13.28,"low":12.78,"amount":157000000,"amplitude":0.0389,"askPrice":13.23,"askSize":465,"bidPrice":13.22,"bidSize":106,"shortable":0,"etf":0,"ttmEps":0.0473,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1724635800000},"adr":0,"adjPreClose":12.86,"symbolType":"stock","openAndCloseTimeList":[[1724376600000,1724383800000],[1724389200000,1724396400000]],"highLimit":14.15,"lowLimit":11.57,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":966494707,"pbRate":5.33,"roa":"--","roe":"0.54%","epsLYR":0.05,"committee":0.029746,"marketValue":12787000000,"floatMarketCap":12780000000,"peRate":279.704018,"changeRate":0.0288,"turnoverRate":0.0124,"status":0,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2024-08-26。"},"requestUrl":"/m/hq/s/000766/tweets","defaultTab":"tweets","newsList":[{"id":"2461038252","title":"通化金马(000766)8月21日主力资金净卖出4437.36万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2461038252","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461038252?lang=zh_cn&edition=full","pubTime":"2024-08-22 09:22","pubTimestamp":1724289764,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年8月21日收盘,通化金马报收于13.09元,下跌3.75%,换手率1.73%,成交量16.67万手,成交额2.2亿元。8月21日的资金流向数据方面,主力资金净流出4437.36万元,占总成交额20.21%,游资资金净流入1040.2万元,占总成交额4.74%,散户资金净流入3397.17万元,占总成交额15.47%。通化金马主营业务:医药产品的研发、生产与销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082200008706.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000766","BK0060","BK0077","BK0239"],"gpt_icon":0},{"id":"2461802396","title":"通化金马(000766)2024年中报简析:净利润增15.7%,盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2461802396","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461802396?lang=zh_cn&edition=full","pubTime":"2024-08-22 06:07","pubTimestamp":1724278027,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期通化金马发布2024年中报。截至本报告期末,公司营业总收入6.49亿元,同比下降10.89%,归母净利润1246.83万元,同比上升15.7%。本报告期通化金马盈利能力上升,毛利率同比增幅0.75%,净利率同比增幅34.51%。其中,毛利率75.23%,同比增0.75%,净利率1.9%,同比增34.51%,销售费用、管理费用、财务费用总计4.5亿元,三费占营收比69.34%,同比增1.14%,每股净资产2.41元,同比减0.75%,每股经营性现金流0.04元,同比减7.28%,每股收益0.01元,同比增15.18%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082200005074.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000766"],"gpt_icon":0},{"id":"2460027115","title":"图解通化金马中报:第二季度单季净利润同比减13.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460027115","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460027115?lang=zh_cn&edition=full","pubTime":"2024-08-20 17:11","pubTimestamp":1724145105,"startTime":"0","endTime":"0","summary":"证券之星消息,通化金马2024年中报显示,公司主营收入6.49亿元,同比下降10.89%;归母净利润1246.83万元,同比上升15.7%;扣非净利润640.14万元,同比下降16.96%;其中2024年第二季度,公司单季度主营收入3.54亿元,同比下降15.79%;单季度归母净利润328.21万元,同比下降13.96%;单季度扣非净利润6.45万元,同比下降97.82%;负债率49.33%,投资收益133.03万元,财务费用3635.11万元,毛利率75.23%。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082000028770.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000766"],"gpt_icon":0},{"id":"2460402273","title":"通化金马最新公告:聘任张玉富先生担任公司总经理","url":"https://stock-news.laohu8.com/highlight/detail?id=2460402273","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460402273?lang=zh_cn&edition=full","pubTime":"2024-08-20 17:04","pubTimestamp":1724144670,"startTime":"0","endTime":"0","summary":"通化金马公告,公司董事会收到总经理张皓琰女士的书面辞职报告,张皓琰女士因个人原因申请辞去公司总经理职务。经董事会提名委员会提名并审核通过,第十一届董事会第六次会议审议通过了《关于聘任总经理的议案》,同意聘任张玉富先生担任公司总经理,其任期自本次董事会审议通过之日起至本届董事会任期届满之日止。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082000027894.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0077","000766","BK0060"],"gpt_icon":0},{"id":"2460902229","title":"通化金马最新公告:2024年上半年净利润同比增长15.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460902229","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460902229?lang=zh_cn&edition=full","pubTime":"2024-08-20 17:04","pubTimestamp":1724144651,"startTime":"0","endTime":"0","summary":"通化金马发布2024年半年度报告,公司2024年上半年实现营业收入6.49亿元,同比下降10.89%;归属于上市公司股东的净利润1246.83万元,同比增长15.69%。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082000027893.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000766"],"gpt_icon":0},{"id":"2460584022","title":"通化金马(000766.SZ)发布上半年业绩,净利润1246.83万元,增长15.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460584022","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460584022?lang=zh_cn&edition=full","pubTime":"2024-08-20 16:56","pubTimestamp":1724144205,"startTime":"0","endTime":"0","summary":"智通财经APP讯,通化金马 发布2024年半年度报告,报告期内,公司实现营业收入6.49亿元,同比下降10.89%。实现归属于上市公司股东的净利润1246.83万元,同比增长15.69%。基本每股收益0.0129元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1166975.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["000766"],"gpt_icon":0},{"id":"2459213128","title":"通化金马:公司正严格按照CDE有关法律、法规及指导原则,积极开展新药上市申请有关工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2459213128","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459213128?lang=zh_cn&edition=full","pubTime":"2024-08-14 18:01","pubTimestamp":1723629704,"startTime":"0","endTime":"0","summary":"通化金马董秘:您好,公司已收到国家药品监督管理局签发的琥珀八氢氨吖啶上市申请登记的《受理通知书》,详见7月24日披露的《关于收到琥珀八氢氨吖啶上市申请登记受理通知书的公告》。投资者:请问:原料药已经受理快20天啦,吖啶片怎么迟迟不去注册提交,谢谢通化金马董秘:您好,公司正严格按照CDE有关法律、法规及指导原则,积极开展新药上市申请有关工作。并根据进展情况及时履行信息披露义务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081400037782.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","000766","BK0077","BK0239"],"gpt_icon":0},{"id":"2459161054","title":"通化金马(000766)8月13日主力资金净卖出1401.11万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459161054","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459161054?lang=zh_cn&edition=full","pubTime":"2024-08-14 09:28","pubTimestamp":1723598883,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年8月13日收盘,通化金马报收于14.14元,下跌1.12%,换手率0.88%,成交量8.5万手,成交额1.2亿元。8月13日的资金流向数据方面,主力资金净流出1401.11万元,占总成交额11.72%,游资资金净流入105.57万元,占总成交额0.88%,散户资金净流入1295.54万元,占总成交额10.84%。近5日资金流向一览见下表:通化金马融资融券信息显示,融资方面,当日融资买入474.48万元,融资偿还629.97万元,融资净偿还155.48万元。通化金马主营业务:医药产品的研发、生产与销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081400016641.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0060","BK0239","000766"],"gpt_icon":0},{"id":"2458701576","title":"通化金马:根据《股票上市规则》等要求,公司对达到信息披露标准的事项,将会及时披露","url":"https://stock-news.laohu8.com/highlight/detail?id=2458701576","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458701576?lang=zh_cn&edition=full","pubTime":"2024-08-12 18:04","pubTimestamp":1723457057,"startTime":"0","endTime":"0","summary":"投资者:请问贵公司琥珀八氢吖啶片何时申报注册上市通化金马董秘:您好,公司已收到国家药品监督管理局签发的琥珀八氢氨吖啶上市申请登记的《受理通知书》,详见7月24日披露的《关于收到琥珀八氢氨吖啶上市申请登记受理通知书的公告》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081200024508.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000766","BK0060","BK0077"],"gpt_icon":0},{"id":"2457367907","title":"通化金马:相关信息请查询国家药品监督管理局药品审评中心官网","url":"https://stock-news.laohu8.com/highlight/detail?id=2457367907","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457367907?lang=zh_cn&edition=full","pubTime":"2024-08-08 18:02","pubTimestamp":1723111369,"startTime":"0","endTime":"0","summary":"证券之星消息,通化金马(000766)08月08日在投资者关系平台上答复投资者关心的问题。投资者:受理号如何在CDE官网查到相关信息,请指导。通化金马董秘:您好,相关信息请查询国家药品监督管理局药品审评中心官网。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024080800035793.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000766","BK0077","BK0060"],"gpt_icon":0},{"id":"2457746166","title":"通化金马:公司按照国家有关规定,加快推进新药注册进度,并根据进展情况及时履行信息披露义务","url":"https://stock-news.laohu8.com/highlight/detail?id=2457746166","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457746166?lang=zh_cn&edition=full","pubTime":"2024-08-05 17:02","pubTimestamp":1722848552,"startTime":"0","endTime":"0","summary":"证券之星消息,通化金马(000766)08月05日在投资者关系平台上答复投资者关心的问题。投资者:您好!目前国内获批的阿尔兹海默症治疗药物都申请了优先申评审批,比如卫材的仑卡奈单抗,绿谷的971。请问公司正在开展的新药注册过程中是否考虑申请优先审批?通化金马董秘:您好,公司按照国家有关规定,加快推进新药注册进度,并根据进展情况及时履行信息披露义务。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024080500023241.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0239","000766","BK0060"],"gpt_icon":0},{"id":"2455905603","title":"7月31日通化金马涨5.27%,南方中证1000ETF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2455905603","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455905603?lang=zh_cn&edition=full","pubTime":"2024-07-31 16:39","pubTimestamp":1722415169,"startTime":"0","endTime":"0","summary":"证券之星消息,7月31日通化金马涨5.27%,收盘报14.37元,换手率2.91%,成交量28.06万手,成交额3.94亿元。重仓通化金马的公募基金请见下表:根据2024基金半年报公募基金重仓股数据,重仓该股的公募基金共8家,其中持有数量最多的公募基金为南方中证1000ETF。南方中证1000ETF目前规模为241.3亿元,最新净值1.9098,较上一交易日上涨0.36%,近一年下跌26.62%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024073100033936.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000766","560110","BK0060","BK0077","BK0239"],"gpt_icon":0},{"id":"2455600207","title":"通化金马:原料药上市申请为新药上市申请关联审评的重要环节","url":"https://stock-news.laohu8.com/highlight/detail?id=2455600207","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455600207?lang=zh_cn&edition=full","pubTime":"2024-07-30 17:04","pubTimestamp":1722330247,"startTime":"0","endTime":"0","summary":"如果单独申请原料药是因为是仿制药?目前,公司正严格按照CDE有关法律、法规及指导原则开展新药上市申请有关工作。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024073000034117.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000766","BK0239","BK0060","BK0077"],"gpt_icon":0},{"id":"2455639636","title":"通化金马:根据《股票上市规则》等要求,公司对达到信息披露标准的事项,将会及时披露","url":"https://stock-news.laohu8.com/highlight/detail?id=2455639636","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455639636?lang=zh_cn&edition=full","pubTime":"2024-07-29 17:04","pubTimestamp":1722243853,"startTime":"0","endTime":"0","summary":"通化金马董秘:您好,公司指定的信息披露媒体为中国证券报、证券时报、上海证券报和巨潮资讯网,有关公司的重大信息,以公司在以上媒体发布的公告为准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072900025577.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000766","BK0077","BK0060"],"gpt_icon":0},{"id":"2455577043","title":"医药股盘初走低,一品红跌超16%,康缘药业跌逾8%,新天药业、通化金马、博瑞医药、键凯科技等跟跌。","url":"https://stock-news.laohu8.com/highlight/detail?id=2455577043","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455577043?lang=zh_cn&edition=full","pubTime":"2024-07-29 09:38","pubTimestamp":1722217106,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"live_wallstreetcn","url":"https://wallstreetcn.com/live/a-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/live/a-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_wallstreetcn","symbols":["BK0229","002873","688166","688356","BK0239","000766","BK0028","300723","BK0188","BK1161","600557","BK1574","BK0077","BK1515","159938","09939","BK0060"],"gpt_icon":0},{"id":"2454318402","title":"通化金马:我公司自主研发的琥珀八氢氨吖啶片,为国家1.1类新药","url":"https://stock-news.laohu8.com/highlight/detail?id=2454318402","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454318402?lang=zh_cn&edition=full","pubTime":"2024-07-26 17:05","pubTimestamp":1721984702,"startTime":"0","endTime":"0","summary":"投资者:公司近期发布了新药原料药上市申请受理公告,有解读认为公司1.1类新药不符合“创新”条件不能申请上市,故而公司退而求其次申请原料药上市。通化金马董秘:您好,我公司自主研发的琥珀八氢氨吖啶片,为国家1.1类新药。现已收到国家药品监督管理局签发的琥珀八氢氨吖啶上市申请登记的《受理通知书》。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072600035155.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0060","BK0239","000766"],"gpt_icon":0},{"id":"2454602392","title":"7月26日通化金马跌6.66%,南方中证1000ETF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2454602392","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454602392?lang=zh_cn&edition=full","pubTime":"2024-07-26 16:14","pubTimestamp":1721981663,"startTime":"0","endTime":"0","summary":"证券之星消息,7月26日通化金马跌6.66%创60日新低,收盘报14.29元,换手率4.67%,成交量45.07万手,成交额6.49亿元。重仓通化金马的公募基金请见下表:根据2024基金半年报公募基金重仓股数据,重仓该股的公募基金共8家,其中持有数量最多的公募基金为南方中证1000ETF。南方中证1000ETF目前规模为241.3亿元,最新净值1.8813,较上一交易日上涨0.05%,近一年下跌28.07%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072600031301.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0239","000766","560110","BK0077"],"gpt_icon":0},{"id":"2454393142","title":"【午后一度跌停,通化金马回应:生产经营一切正常,后续会提交琥珀八氢氨吖啶片剂上市申请】金十数据7月26日讯,通化金马午后大跌,一度触及跌停。","url":"https://stock-news.laohu8.com/highlight/detail?id=2454393142","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454393142?lang=zh_cn&edition=full","pubTime":"2024-07-26 15:03","pubTimestamp":1721977425,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0239","000766","BK0077","BK0060"],"gpt_icon":0},{"id":"2454836090","title":"通化金马闪崩跌超9%,成交额超5亿元。该股昨日盘初亦闪崩跌超8%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2454836090","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454836090?lang=zh_cn&edition=full","pubTime":"2024-07-26 14:32","pubTimestamp":1721975530,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0077","BK0060","BK0239","000766"],"gpt_icon":0},{"id":"2454331612","title":"解构“妖股” 通化金马","url":"https://stock-news.laohu8.com/highlight/detail?id=2454331612","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454331612?lang=zh_cn&edition=full","pubTime":"2024-07-25 23:07","pubTimestamp":1721920020,"startTime":"0","endTime":"0","summary":" 这种情况下,当通化金马去年宣布琥珀八氢氨吖啶片完成三期临床试验时,公司股价一飞冲天,在A股市场博得不少关注。 2023年12月12日俨然成为通化金马热度的分界线。 重要股东高位减持的同时,通化金马也并未受到太多专业机构关注。在可查询的定期公告中,机构投资者只持有少量通化金马股份。 丁先生是通化金马股东大会首位到会的外部股东。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/s/2024-07-25/doc-incfmawn2352727.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/s/2024-07-25/doc-incfmawn2352727.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0077","BK0239","000766","BK0060"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"1997-04-30","address":"吉林省通化市二道江区金马路999号","stockEarnings":[{"period":"1week","weight":-0.0793},{"period":"1month","weight":-0.1878},{"period":"3month","weight":-0.1772},{"period":"6month","weight":-0.1552},{"period":"1year","weight":1.1832},{"period":"ytd","weight":-0.3365}],"companyName":"通化金马药业集团股份有限公司","boardCode":"AI0027","perCapita":"20190股","boardName":"医药制造业","registeredCapital":"96649万元","compareEarnings":[{"period":"1week","weight":-0.0087},{"period":"1month","weight":-0.0164},{"period":"3month","weight":-0.0759},{"period":"6month","weight":-0.0501},{"period":"1year","weight":-0.0739},{"period":"ytd","weight":-0.0405}],"survey":" 通化金马药业集团股份有限公司主要从事医药产品的研发、生产与销售。主要产品有复方嗜酸乳杆菌片、风湿祛痛胶囊、清肝健脾口服液、芩石利咽口服液。公司经历多年发展,获得行业认可,荣获“中华民族医药百强品牌企业”,2023年获得“2022-2023年度中国医药制造业百强”等称号。子公司圣泰生物先后被评为哈尔滨市“小巨人”企业、黑龙江省民营科技“巨星”企业、黑龙江省专精特新小巨人企业、国家高新技术企业、国家火炬计划重点高新技术企业等多项荣誉。","serverTime":1724514854060,"listedPrice":7.23,"stockholders":"47845人(较上一季度减少19.52%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"通化金马(000766)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供通化金马(000766)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"通化金马,000766,通化金马股票,通化金马股票老虎,通化金马股票老虎国际,通化金马行情,通化金马股票行情,通化金马股价,通化金马股市,通化金马股票价格,通化金马股票交易,通化金马股票购买,通化金马股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"通化金马(000766)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供通化金马(000766)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}